Translating Phage Promise into Practice: Building the Evidence, Infrastructure & Oversight for Clinical Adoption

• Examining how phage therapy can be integrated into antimicrobial resistance strategies through real-world evidence generation and clinical trial design
• Discussing how coordinated reference networks, surveillance data, and stewardship systems can inform safe, scalable phage deployment across diverse healthcare settings
• Exploring what global infrastructure and cross-sector collaboration are needed to transition phage from exceptional use to a reliable therapeutic tool

Speakers:

Colin Brown

DD

The UK Health Security Agency (UKHSA)

Mark Sutton

Professor for Antimicrobial Therapy & Scientific Leader - AMR and Healthcare Biotechnology

King’s College London & UK Health Security Agency